Stay updated on Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial

Sign up to get notified when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record presents details of the completed Phase 2 nemolizumab study in adolescents with atopic dermatitis, including eligibility, treatment, locations, outcomes, and results-related information. It also includes study history, a linked publication, and study documents.
    Difference
    69%
    Check dated 2026-11-08T19:08:54.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer site revision changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-01T18:54:30.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide notice announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T20:37:02.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T22:33:05.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.0 to v3.7.1 in the page footer.
    Difference
    0.2%
    Check dated 2026-10-11T22:33:15.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating the study record is inaccessible. Added elements include a basic 403 header and a site footer with a Home link and a revision note, reflecting an access/permissions change rather than updates to the study data.
    Difference
    21%
    Check dated 2026-09-20T20:52:02.000Z thumbnail image

Stay in the know with updates to Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nemolizumab in Adolescent AD: Pharmacokinetics and Safety Clinical Trial page.